Peter Greenleaf
Overview
Peter Greenleaf received an average of $6M in total compensation, including $612K in salary, at Aurinia Pharmaceuticals from 2019 to 2021. Peter Greenleaf also received an average of $2M at Avalo Therapeutics from 2017 to 2019, an average of $4M at Sucampo Pharmaceuticals from 2014 to 2016, and an average of $262K at Histogenics between 2013 and 2014.
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Aurinia PharmaceuticalsChief Executive Officer
Aurinia PharmaceuticalsChief Executive Officer
Aurinia PharmaceuticalsChief Executive Officer
Avalo TherapeuticsFormer Chief Executive Officer and former Principal Executive Officer
Avalo TherapeuticsFormer Chief Executive Officer
Avalo TherapeuticsFormer Chief Executive Officer
Sucampo PharmaceuticalsChief Executive Officer and Chairman of the Board of Directors
Sucampo PharmaceuticalsChief Executive Officer and Chairman of the Board of Directors
HistogenicsFormer Director, President and Chief Executive Officer
Sucampo PharmaceuticalsChief Executive Officer and Chairman of the Board of Directors
Source: SEC filings on April 18, 2022, May 10, 2021, April 28, 2020, June 19, 2019, April 21, 2017, and April 28, 2015.
Related executives
We found 37 more executives who work or worked at Aurinia Pharmaceuticals, Avalo Therapeutics, Sucampo Pharmaceuticals, andHistogenics.
Garry Neil
Avalo Therapeutics
Chief Executive Officer
Stephen Smolinski
Avalo Therapeutics
Former Chief Commercial Officer
Michael Cola
Avalo Therapeutics
Chief Executive Officer
Christopher Sullivan
Avalo Therapeutics
Chief Financial Officer
Schond Greenway
Avalo Therapeutics
Chief Financial Officer
H Wilkins
Avalo Therapeutics
Chief Medical Officer
Max Donley
Aurinia Pharmaceuticals
EVP, Operations and Strategy
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
News
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2021 pay falls 88% to $1.2M
April 18, 2022
Aurinia Pharmaceuticals CEO Peter Greenleaf's 2020 pay jumps 1,353% to $11M
May 10, 2021
Avalo Therapeutics Chairman Simon Pedder's 2019 pay jumps 13,562% to $3.8M
April 28, 2020
Avalo Therapeutics CEO Peter Greenleaf's 2018 pay jumps 17,372% to $5.1M
June 19, 2019